Primary Ms
Research payments
$8,750,467
Through program year 2024, $8,750,467 in research payments was reported against Primary Ms, across 648 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $2,066,229 | 88 |
| 2023 | Research | $1,435,275 | 80 |
| 2022 | Research | $1,441,842 | 109 |
| 2021 | Research | $1,044,739 | 126 |
| 2020 | Research | $1,211,702 | 142 |
| 2019 | Research | $1,550,680 | 103 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Derrick Robertson Tampa, FL Named on 49 payments
- Emmanuelle Waubant San Francisco, CA Named on 47 payments
- Pavle Repovic Seattle, WA Named on 22 payments
- Erin Longbrake North Haven, CT Named on 21 payments
- Evanthia Bernitsas Detroit, MI Named on 19 payments
- Robert Naismith Saint Louis, MO Named on 18 payments
- Barbara Obrien Cordova, TN Named on 16 payments
- Ellen Lathi Brighton, MA Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.